SOLID DISPERSIONS OF INSOLUBLE DRUGS AND METHODS OF THEIR PREPARATION Russian patent published in 2018 - IPC A61K31/42 A61K47/30 A61K47/00 A61K9/14 A61K9/20 A61J3/02 A61P25/00 A61P25/28 

Abstract RU 2646491 C2

FIELD: pharmaceuticals.

SUBSTANCE: present invention refers to solid pharmaceutical dispersion, which contains 3-(4-benzyloxyphenyl)-isoxazol-5-ylmethyl carbamic acid as the active ingredient, the water soluble polymer that has the glass transition temperature below the melting point of the active ingredient as the carrying agent and the softening agent. Solid dispersion is prepared by means of melt extrusion. Water-soluble polymer is selected from polyvinylpyrrolidone, hypromellose acetate succinate and combinations thereof. Softener is selected from the group, which consists of D-alpha-tocopheryl polyethylene glycol 1000 succinate, polyethylene glycol 400 and combinations thereof. Method for preparing the solid dispersion and the pharmaceutical composition that includes the solid dispersion are also disclosed and are intended for the treatment of degenerative brain disease.

EFFECT: solid dispersion of the present invention increases the solubility and dissolution rate of the active ingredient, which is the insoluble drug, for effective improvement of bioavailability during oral administration.

9 cl, 3 dwg, 13 tbl, 7 ex

Similar patents RU2646491C2

Title Year Author Number
PHARMACEUTICAL COMPOSITION FOR INHIBITING APOPTOSIS OF NEURONS OR NEURODEGENERATION 2011
  • Park Cheol Kheung
  • Min Khie Kiung
  • Park In Suk
  • Lim Mi Dzung
  • Li Dzi Vong
  • Chung Dzin Jong
  • Joon Jeo Dzin
  • Park Dzoo Yang
RU2722018C2
PHARMACEUTICAL COMPOSITION FOR INHIBITING NEURONAL APOPTOSIS OR NEURODEGENERATION 2011
  • Park Cheol Kheung
  • Min Khie Kiung
  • Park In Suk
  • Lim Mi Dzung
  • Li Dzi Vong
  • Chung Dzin Jong
  • Joon Jeo Dzin
  • Park Dzoo Yang
RU2586772C2
PRO-MEDICATION COMPOSITION FOR STRUGGLE AGAINST HEPAPATITIS C VIRUS 2006
  • Akhmed Khashim A.
  • Alfredson Tomas Vernon
  • Birudaraj Kondamraj
  • Brandl Majkl Tomas
  • Pkhuapradit Vantani
  • Shakh Navnit Khargovindas
  • Stefanidis Dimitros
RU2435592C2
PERORAL SOLID DOSAGE FORM WITH MYCOPHENOLIC ACID OR ITS SALT FOR USE AS AN IMMUNODEPRESSANT FOR TREATMENT OR PREVENTION OF ORGAN OR TISSUE TRANSPLANT REJECTION AND METHOD FOR PRODUCTION THEREOF 2016
  • Khazanova Elena Sergeevna
  • Nogaj Sergej Yurevich
  • Filippova Evgeniya Aleksandrovna
RU2670447C2
SUBSTITUTED AZOL DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THESE DERIVATIVES, AND METHODS OF TREATING PARKINSON'S DISEASE WITH USING THESE DERIVATIVES 2010
  • Park Cheol-Khong
  • Min Khe-Kjung
  • Lim Mi-Dzhung
  • Li Dzhi-Von
  • Chung Dzhin-Jon
  • Rju Chun-Kho
  • Jun Jeo-Dzhin
  • Dzhi Mi-Kjung
  • Park Dzhu-Jong
RU2578596C2
EXTRUDATE WITH SODIUM MYCOPHENOLATE TO PRODUCE PERORAL SOLID DOSAGE FORM 2018
  • Khazanova Elena Sergeevna
  • Nogaj Sergej Yurevich
  • Filippova Evgeniya Aleksandrovna
RU2723255C2
PHARMACEUTICAL COMPOSITION 2018
  • Geissler Simon
  • Jeschke Martina
  • Boniforte Patrizia
  • Weigandt Markus
RU2809144C2
PHARMACEUTICAL COMPOSITION FOR HIV INFECTION TREATMENT 2016
  • Khazanova Elena Sergeevna
  • Nogaj Sergej Yurevich
  • Yakovlev Dmitrij Vladimirovich
RU2619840C1
THE METHOD OF OBTAINING A PHARMACEUTICAL COMPOSITION WITH TACROLIMUS (VARIANTS) AND A PHARMACEUTICAL COMPOSITION OBTAINED BY THESE METHODS 2022
  • Khazanova Elena Sergeevna
  • Merkulova Evgeniya Aleksandrovna
RU2792098C1
COMPOSITION AND DOSAGE FORM CONTAINING SOLID OR SEMISOLID MATRIX 2006
  • Rozenberg Jorg
  • Mehgerljajn Markus
  • Brajtenbakh Jorg
RU2423997C9

RU 2 646 491 C2

Authors

Baek Mioung Ki

Pegan Ogasten

Dates

2018-03-05Published

2013-11-07Filed